Synlogic Inc (NASDAQ:SYBX) Shorts Rose By 0.75%

It was showed an increase on Synlogic Inc (NASDAQ:SYBX)’s shorted shares with 0.75%. It was published in November by FINRA the 1.08M shorted shares on SYBX. Previously was reported up change of 0.75% from 1.07M shares. Synlogic Inc (NASDAQ:SYBX) has 133,100 shares average volume. It’ll cost 8 days for SYBX to recover its previous position. Synlogic Inc’s shorted shares float is 7.56%.

At traded at $7.99 lastly.It’s downtrending since November 10, 2017 and is 30.46% up. SYBX underperformed the S&P500 by 46.08%.

Synlogic, Inc. develops synthetic biotic medicines for the treatment of patients with urea cycle disorder and phenylketonuria.The company has $203.19 million market cap.

A couple more Synlogic, Inc. (NASDAQ:SYBX) news were posted by: Businesswire.com which released on November 06, 2018 “Clinical Candidate in Immuno-Oncology at the Society for Immunotherapy of Cancer’s (SITC) 33”, also Businesswire.com on November 07, 2018 posted “ADDING and REPLACING Ra Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate …”, the next Businesswire.com is “Synlogic Announces Third Quarter 2018 Conference Call and Webcast” on November 07, 2018. Businesswire.com has article titled “Synlogic to Host Analyst & Investor Event at the Society for Immunotherapy of Cancer (SITC) 2018 Annual Meeting”.

Synlogic, Inc. (NASDAQ:SYBX) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.